Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
Open Access
- 12 January 2018
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 103 (3) , 1214-1223
Abstract
Context Androgen excess in women is predominantly due to underlying polycystic ovary syndrome (PCOS). However, there is a lack of clarity regarding patterns and severity of androgen excess that should be considered predictive of non-PCOS pathology. Objective We examined the diagnostic utility of simultaneous measurement of serum dehydroepiandrosterone sulfate (DHEAS), androstenedione (A4), and testosterone (T) to delineate biochemical signatures and cutoffs predictive of non-PCOS disorders in women with androgen excess. Design Retrospective review of all women undergoing serum androgen measurement at a large tertiary referral center between 2012 and 2016. Serum A4 and T were measured by tandem mass spectrometry and DHEAS by immunoassay. Patients with at least one increased serum androgen underwent phenotyping by clinical notes review. Results In 1205 women, DHEAS, A4, and T were measured simultaneously. PCOS was the most common diagnosis in premenopausal (89%) and postmenopausal women (29%). A4 was increased in all adrenocortical carcinoma (ACC) cases (n = 15) and T in all ovarian hyperthecosis (OHT) cases (n = 7); all but one case of congenital adrenal hyperplasia (CAH; n = 18) were identified by increased levels of A4 and/or T. In premenopausal women, CAH was a prevalent cause of severe A4 (59%) and T (43%) excess; severe DHEAS excess was predominantly due to PCOS (80%). In postmenopausal women, all cases of severe DHEAS and A4 excess were caused by ACC and severe T excess equally by ACC and OHT. Conclusions Pattern and severity of androgen excess are important predictors of non-PCOS pathology and may be used to guide further investigations as appropriate.Keywords
This publication has 46 references indexed in Scilit:
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome SocietyHuman Reproduction Update, 2011
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its DisordersEndocrine Reviews, 2011
- High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptomsFertility and Sterility, 2010
- Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratomaEuropean Journal of Endocrinology, 2010
- Type 5 17β-Hydroxysteroid Dehydrogenase (AKR1C3) Contributes to Testosterone Production in the Adrenal ReticularisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2008
- Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic womenGynecological Endocrinology, 2008
- Dehydroepiandrosterone Replacement in Women with Adrenal InsufficiencyNew England Journal of Medicine, 1999
- Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing turnours*Clinical Endocrinology, 1994
- A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopeciaClinical Endocrinology, 1994